Clicky

Depression

Alzheimer’s May Start Sooner for People With Anxiety, Depression History

A history of either anxiety or depression was inversely associated with the age when Alzheimer’s disease started, a retrospective analysis suggested. People with Alzheimer’s disease who had a past diagnosis of anxiety were 3 years younger than other Alzheimer’s patients when they developed the disease, reported Zachary Miller, MD, of the University of California San […]

Alzheimer’s May Start Sooner for People With Anxiety, Depression History Read More »

COVID-19 Blood Flow Changes May Be Reason for ‘Brain Fog,’ Depression

Newswise — Rockville, Md. (February 24, 2021)—A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a role in mood changes and cognitive difficulties that people with the disease face during illness and recovery. The review is published in Physiological Reports. COVID-19, the disease caused by the SARS CoV-2

COVID-19 Blood Flow Changes May Be Reason for ‘Brain Fog,’ Depression Read More »

Otsuka, Click Therapeutics kick off decentralized pivotal trial for depression digital therapeutics

Otsuka Pharmaceutical and Click Therapeutics have announced the launch of a new, fully remote clinical trial being conducted on Verily’s Project Baseline platform. Called the Mirai study, it will be measuring a digital therapeutics intervention’s effectiveness in reducing symptoms of depression among adults who have a major depressive disorder (MDD) diagnosis and are on antidepressant monotherapy.

Otsuka, Click Therapeutics kick off decentralized pivotal trial for depression digital therapeutics Read More »

Otsuka and Click Therapeutics Initiate First-of-its-Kind Fully Remote Clinical Trial Using Digital Therapeutics as Adjunctive Therapy in Adults With Major Depressive Disorder

PRINCETON, N.J. & NEW YORK–(BUSINESS WIRE)– Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) and Click Therapeutics, Inc. announce the initiation of the Mirai study, a landmark fully remote clinical trial to investigate the effectiveness of digital therapeutics in reducing depressive symptoms in adults diagnosed with major depressive disorder (MDD) who are on antidepressant monotherapy. The

Otsuka and Click Therapeutics Initiate First-of-its-Kind Fully Remote Clinical Trial Using Digital Therapeutics as Adjunctive Therapy in Adults With Major Depressive Disorder Read More »

ADHD and Depression: Links, Mistaken Symptoms, Medication

More than half of people diagnosed with attention deficit hyperactivity disorder (ADHD or ADD) will experience depression in their lifetime. And 30 to 40 percent of individuals diagnosed with depression also have ADHD. The comorbid connection between ADHD and depression is strong. And with that connection comes an increased risk for two common scenarios that

ADHD and Depression: Links, Mistaken Symptoms, Medication Read More »

COVID-19 Blood Flow Changes May Be Reason for ‘Brain Fog,’ Depression

Newswise — Rockville, Md. (February 24, 2021)—A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a role in mood changes and cognitive difficulties that people with the disease face during illness and recovery. The review is published in Physiological Reports. COVID-19, the disease caused by the SARS CoV-2

COVID-19 Blood Flow Changes May Be Reason for ‘Brain Fog,’ Depression Read More »

Depressed Americans are starting to lose access to telehealth therapy. Here’s what Congress is doing about it

While Medicaid still covers telehealth appointments as long as the public health emergency is in effect, some private insurance companies have stopped covering it. Author: weareiowa.com Published: 10:30 PM CST February 23, 2021 Updated: 10:47 PM CST February 23, 2021

Depressed Americans are starting to lose access to telehealth therapy. Here’s what Congress is doing about it Read More »